Regulators are supposed to abide by society's “bargain” with them: Civil servants are granted lifetime tenure and protected ...

(NASDAQ: IMNN) (the “Company”), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that the Compensation Committee of the Company’s Board of ...

Antibiotic resistance is a growing public health problem globally. The problem is exacerbated by the fact that some bacteria ...

The posters are available on the Posters and Publications page of the Company’s website.

Cryoport has formed a strategic partnership with fertility technology company TMRW Life Sciences to provide fertility clinics ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based ...

Ever since recombinant DNA has been used to develop and manufacture vaccines, antivaxxers have portrayed it as evil. This ...

DelveInsight’s, “Peripheral Arterial Disease Pipeline Insight 2024” report provides comprehensive insights about 18+ ...

FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics”) and Charles River Laboratories ("Charles River”), a leading global drug discovery, development, testing, and manufacturing solutions provider ...

The global nucleic acid isolation and purification market is set to experience significant growth, projected to reach USD ...

Under the terms of the merger agreement, Kayak Mergeco, Inc., Kintara's wholly-owned subsidiary, will merge with and into the private-company TuHURA, with TuHURA surviving the merger and becoming the ...

Global Plasmid Purification Market was valued at approximately USD 1.78 billion in 2023, exhibiting a robust CAGR of 11.69% throughout the forecast period from 2024 to 2032. Read the Market Summary ...